BLISS GVS PHARMA share price has plunged 10% and is presently trading at Rs 111.9.
Meanwhile, the BSE HEALTHCARE index is at 43,143.5 (up 0.6%).
Among the top losers in the BSE HEALTHCARE index today are Procter & Gamble Health (down 2.1%) and CAPLIN POINT (down 1.1%).
LAURUS LABS (up 2.8%) and ASTER DM HEALTHCARE (up 2.5%) are among the top gainers today.
Over the last one year, BLISS GVS PHARMA has moved up from Rs 82.5 to Rs 111.9, registering a gain of Rs 29.4 (up 35.6%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 43,143.5, registering a gain of 56.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 206.8%), Glenmark Pharma (up 123.9%) and SUVEN PHARMACEUTICALS (up 123.2%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,109.2 (up 0.1%).
The top gainers among the BSE Sensex today are ITC (up 3.3%) and Axis Bank (up 2.5%). The most traded stocks in the BSE Sensex are Indusind Bank and ITC.
In the meantime, NSE Nifty is at 24,393.2 . Indusind Bank and NTPC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,109.2, registering a gain of 15,537.3 points (up 24.1%).
BLISS GVS PHARMA net profit grew 53.8% YoY to Rs 221 million for the quarter ended June 2024, compared to a profit of Rs 144 million a year ago. Net sales rose 15.1% to Rs 1,836 million during the period as against Rs 1,595 million in April-June 2023.
For the year ended March 2024, BLISS GVS PHARMA reported 6.3% increase in net profit to Rs 816 million compared to net profit of Rs 767 million during FY23. Revenue of the company grew 2.5% to Rs 7,702 million during FY24.
The current Price to earnings ratio of BLISS GVS PHARMA, based on rolling 12 month earnings, stands at 13.2.
Equitymaster requests your view! Post a comment on "BLISS GVS PHARMA Plunges 10%; BSE HEALTHCARE Index Up 0.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!